Patricia T. Jacobson
Research Subjects
Research Interests
Patricia T. Jacobson has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan B. Overdevest
Department of Otolaryngology Columbia University Medical Center New York New York USA
2 shared publications - Alan Thevenet N. Tita
Department of Obstetrics and Gynecology University of Alabama at Birmingham Birmingham Alabama USA
1 shared publication - Ann M. Bruno
Department of Obstetrics and Gynecology University of Utah Health Salt Lake City Utah USA
1 shared publication - Ashley N. Battarbee
Department of Obstetrics and Gynecology, Center for Women’s Reproductive Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA
1 shared publication - Dani Dumitriu
Center for Early Relational Health, Columbia University, New York, NY, USA
1 shared publication - David A. Gudis
Department of Otolaryngology–Head & Neck Surgery Columbia University Irving Medical Center New York New York USA
1 shared publication
Latest Publications
- 22 January 2025
- Published by Oxford University Press (OUP) in Chemical Senses
- Vol. 50
Prevalence of olfactory dysfunction among postpartum women and impact of SARS-CoV-2 infection during pregnancy
Olfactory dysfunction resulting from COVID-19 has imparted a lasting impact on olfaction among the general public, including pregnant women contracting SARS-CoV-2 infection. While olfactory dysfunction can impact physical, mental, and psychosocial well-being, there has been little research on olfaction during pregnancy and postpartum, nor the impact of SARS-CoV-2 infection on olfaction while pregnant. Therefore, the primary study aims are to evaluate olfaction in the postpartum period and determine the impact of antecedent SARS-CoV-2 infection. We recruited two cohorts of postpartum women, those with a history of SARS-CoV-2 infection before or during pregnancy (COVID cohort; n = 109) and those without (non-COVID cohort; n = 226), and evaluated their olfaction during the postpartum period by administering the University of Pennsylvania Smell Identification Test. Participants were queried about demographics, past SARS-CoV-2 infections, self-reported sense of smell (both in overall ability to smell and for the presence of qualitative smell issues such as parosmia and phantosmia), and perceived cause of smell loss, if any. We found significantly fewer postpartum women with normosmia capabilities in both COVID (27%) and non-COVID (46%) cohorts compared to normative data for aged-matched (30 to 39 years) women (83%). Women in the non-COVID cohort had significantly higher UPSIT scores and mean subjective olfaction ratings than those in the COVID cohort (95% CI [0.77,2.41] and 95% CI [−0.83,7.34], respectively). This study reflects the largest published cohort of postpartum women evaluated for olfactory function with standardized psychophysical testing. Our findings suggest both postpartum and SARS-CoV-2 infection are associated with diminished smell function.
- 22 January 2025
- Published by Oxford University Press (OUP) in Chemical Senses
- Vol. 50
Prevalence of olfactory dysfunction among postpartum women and impact of SARS-CoV-2 infection during pregnancy
Olfactory dysfunction resulting from COVID-19 has imparted a lasting impact on olfaction among the general public, including pregnant women contracting SARS-CoV-2 infection. While olfactory dysfunction can impact physical, mental, and psychosocial well-being, there has been little research on olfaction during pregnancy and postpartum, nor the impact of SARS-CoV-2 infection on olfaction while pregnant. Therefore, the primary study aims are to evaluate olfaction in the postpartum period and determine the impact of antecedent SARS-CoV-2 infection. We recruited two cohorts of postpartum women, those with a history of SARS-CoV-2 infection before or during pregnancy (COVID cohort; n = 109) and those without (non-COVID cohort; n = 226), and evaluated their olfaction during the postpartum period by administering the University of Pennsylvania Smell Identification Test. Participants were queried about demographics, past SARS-CoV-2 infections, self-reported sense of smell (both in overall ability to smell and for the presence of qualitative smell issues such as parosmia and phantosmia), and perceived cause of smell loss, if any. We found significantly fewer postpartum women with normosmia capabilities in both COVID (27%) and non-COVID (46%) cohorts compared to normative data for aged-matched (30 to 39 years) women (83%). Women in the non-COVID cohort had significantly higher UPSIT scores and mean subjective olfaction ratings than those in the COVID cohort (95% CI [0.77,2.41] and 95% CI [−0.83,7.34], respectively). This study reflects the largest published cohort of postpartum women evaluated for olfactory function with standardized psychophysical testing. Our findings suggest both postpartum and SARS-CoV-2 infection are associated with diminished smell function.
- 16 June 2023
- Published by Elsevier in Operative Techniques in Otolaryngology-Head and Neck Surgery
- Vol. 34 (3) , e27-e30
Optimizing techniques for in-office endoscopic transnasal sphenopalatine ganglion block injections
- 16 June 2023
- Published by Elsevier in Operative Techniques in Otolaryngology-Head and Neck Surgery
- Vol. 34 (3) , e27-e30
Optimizing techniques for in-office endoscopic transnasal sphenopalatine ganglion block injections